Literature DB >> 15070730

Functional association between Wwox tumor suppressor protein and p73, a p53 homolog.

Rami I Aqeilan1, Yuri Pekarsky, Juan J Herrero, Alexey Palamarchuk, Jean Letofsky, Teresa Druck, Francesco Trapasso, Shuang-Yin Han, Gerry Melino, Kay Huebner, Carlo M Croce.   

Abstract

The WWOX gene is a recently cloned tumor suppressor gene that spans the FRA16D fragile region. Wwox protein contains two WW domains that are generally known to mediate protein-protein interaction. Here we show that Wwox physically interacts via its first WW domain with the p53 homolog, p73. The tyrosine kinase, Src, phosphorylates Wwox at tyrosine 33 in the first WW domain and enhances its binding to p73. Our results further demonstrate that Wwox expression triggers redistribution of nuclear p73 to the cytoplasm and, hence, suppresses its transcriptional activity. In addition, we show that cytoplasmic p73 contributes to the proapoptotic activity of Wwox. Our findings reveal a functional cross-talk between p73 and Wwox tumor suppressor protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070730      PMCID: PMC384759          DOI: 10.1073/pnas.0400805101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage.

Authors:  Z M Yuan; H Shioya; T Ishiko; X Sun; J Gu; Y Y Huang; H Lu; S Kharbanda; R Weichselbaum; D Kufe
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

Review 2.  The WW domain: linking cell signalling to the membrane cytoskeleton.

Authors:  Jane L Ilsley; Marius Sudol; Steven J Winder
Journal:  Cell Signal       Date:  2002-03       Impact factor: 4.315

3.  WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.

Authors:  A K Bednarek; C L Keck-Waggoner; R L Daniel; K J Laflin; P L Bergsagel; K Kiguchi; A J Brenner; C M Aldaz
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

4.  Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.

Authors:  N S Chang; N Pratt; J Heath; L Schultz; D Sleve; G B Carey; N Zevotek
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

5.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.

Authors:  A Yang; N Walker; R Bronson; M Kaghad; M Oosterwegel; J Bonnin; C Vagner; H Bonnet; P Dikkes; A Sharpe; F McKeon; D Caput
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

6.  WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

Authors:  A J Paige; K J Taylor; C Taylor; S G Hillier; S Farrington; D Scott; D J Porteous; J F Smyth; H Gabra; J E Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 7.  FRA3B and other common fragile sites: the weakest links.

Authors:  K Huebner; C M Croce
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

8.  Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells.

Authors:  K Ried; M Finnis; L Hobson; M Mangelsdorf; S Dayan; J K Nancarrow; E Woollatt; G Kremmidiotis; A Gardner; D Venter; E Baker; R I Richards
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

9.  Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53.

Authors:  T J Grob; U Novak; C Maisse; D Barcaroli; A U Lüthi; F Pirnia; B Hügli; H U Graber; V De Laurenzi; M F Fey; G Melino; A Tobler
Journal:  Cell Death Differ       Date:  2001-12       Impact factor: 15.828

10.  Physical interaction with Yes-associated protein enhances p73 transcriptional activity.

Authors:  S Strano; E Munarriz; M Rossi; L Castagnoli; Y Shaul; A Sacchi; M Oren; M Sudol; G Cesareni; G Blandino
Journal:  J Biol Chem       Date:  2001-01-24       Impact factor: 5.157

View more
  103 in total

1.  A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development.

Authors:  Stefan White; Jacqueline Hewitt; Erin Turbitt; Yvonne van der Zwan; Remko Hersmus; Stenvert Drop; Peter Koopman; Vincent Harley; Martine Cools; Leendert Looijenga; Andrew Sinclair
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

Review 2.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

Review 3.  Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.

Authors:  Amjad Farooq
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

Review 4.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

5.  NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.

Authors:  Zaidoun Salah; Sherri Cohen; Ella Itzhaki; Rami I Aqeilan
Journal:  Cell Cycle       Date:  2013-10-07       Impact factor: 4.534

6.  Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

Authors:  Mohammad Abu-Odeh; Tomer Bar-Mag; Haiming Huang; TaeHyung Kim; Zaidoun Salah; Suhaib K Abdeen; Marius Sudol; Dana Reichmann; Sachdev Sidhu; Philip M Kim; Rami I Aqeilan
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

Review 7.  Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase.

Authors:  Yao Chang; Yu-Yan Lan; Jenn-Ren Hsiao; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-07

8.  Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype.

Authors:  Suhaib K Abdeen; Sara Del Mare; Sadeeq Hussain; Muhannad Abu-Remaileh; Zaidoun Salah; John Hagan; Maysoon Rawahneh; Xin-An Pu; Stacey Russell; Janet L Stein; Gary S Stein; Jane B Lian; Rami I Aqeilan
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

Review 9.  WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

Authors:  C Marcelo Aldaz; Brent W Ferguson; Martin C Abba
Journal:  Biochim Biophys Acta       Date:  2014-06-14

10.  WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy.

Authors:  John H Ludes-Meyers; Hyunsuk Kil; Maria I Nuñez; Claudio J Conti; Jan Parker-Thornburg; Mark T Bedford; C Marcelo Aldaz
Journal:  Genes Chromosomes Cancer       Date:  2007-12       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.